Back
ACVC Premium Access

Cost savings and outcomes with stepdown versus ICU management of patients with cardiogenic shock supported by Impella 5.5 percutaneous left ventricular assist devices

Session: Predicting, assessing and managing cardiogenic shock
Topic: Nonpharmacological Treatment
Speaker: Doctor A. Carnicelli (Charleston, US)
Event: ESC Acute CardioVascular Care 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Anthony Carnicelli

Medical University of South Carolina, Charleston (United States of America)
1 presentation
0 follower

8 more presentations in this session

Predictors of heart failure development following acute coronary syndrome in young adults

Speaker: Doctor L. Brochado (Almada, PT)

Access
Abstract
Slides
Like
Thumbnail

Descriptive analysis of factors associated with the development of cardiogenic shock in patients with takotsubo syndrome

Speaker: Doctor A. Rivas Garcia (Seville, ES)

Access
Abstract
Slides
Like
Thumbnail

Elevated glucose levels at 24 hours predict mortality in cardiogenic shock

Speaker: Doctor A. Cesari (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

The impact of sex on outcomes and interaction with temporary mechanical circulatory support in cardiogenic shock: insights from the Altshock-2 Registry

Speaker: Doctor M. Bertaina (Turin, IT)

Access
Abstract
Slides
Like
Thumbnail

Hemocompatibility related complications in impella 5+ patients treated with bivalirudine and dual antiplatelet therapy

Speaker: Doctor M. Bandini (Florence, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Predicting, assessing and managing cardiogenic shock

Speakers: Doctor A. Carnicelli, Doctor L. Brochado, Doctor A. Rivas Garcia, Doctor A. Cesari, Doctor M. Bertaina...
Access
Like
Thumbnail

About the event

Image

ESC Acute CardioVascular Care 2025

14 March - 15 March 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources